Send Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
FDA telah menyetujui injeksi terlipressin untuk meningkatkan fungsi ginjal pada orang dewasa dengan sindrom hepatorenal (HRS) dengan pengurangan cepat dalam fungsi ginjal. Terlipressin adalah obat yang disetujui FDA pertama untuk kondisi ini. Penyakit atau kondisi HRS ditandai oleh
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.